✦ LIBER ✦

Primary systemic therapy for operable breast cancer patients: the need for the new generation of trial design

✍ Scribed by Ricardo H. Alvarez; Gabriel N. Hortobagyi

Publisher: Springer US
Year: 2010
Tongue: English
Weight: 197 KB
Volume: 124
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-010-1212-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Local control and the sequencing of adju

Local control and the sequencing of adjuvant systemic therapy with primary radiation for patients with early breast cancer

✍ Beryl McCormick; Thomas Hakes; Joachim Yahalom; David Kinne; Larry Norton 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 216 KB

Exemestane as primary systemic treatment

Exemestane as primary systemic treatment for hormone receptor positive post-menopausal breast cancer patients: a phase II trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-17)

✍ Brigitte Mlineritsch; Christoph Tausch; Christian Singer; Gero Luschin-Ebengreut 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 267 KB

Pathologic findings on re-excision of th

Pathologic findings on re-excision of the primary site in breast cancer patients considered for treatment by primary radiation therapy

✍ Stuart J. Schnitt; James L. Connolly; Urmila Khettry; Gwen Mazoujian; Mark Brenn 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 940 KB

Randomized adjuvant trial to evaluate th

Randomized adjuvant trial to evaluate the addition of tamoxifen and PSK to chemotherapy in patients with primary breast cancer: 5-year results from the nishi-nippon group of the adjuvant chemoendocrine therapy for breast cancer organization

✍ Masakazu Toil; Takao Hattori; Masanobu Akagi; Kiyoshi Lnokuchi; Kunzo Orita; Kei 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 714 KB

Background. A randomized adjuvant trial was conducted from October 1982 to January 1985 to evaluate the addition of tamoxifen (TAM) to combination chemotherapy with perioperative mitomycin C (MMC) and ftorafur (FT) for patients with estrogen receptor (ER)-positive tumors and the addition of PSK, a b

The Perceived Adjustment to Chronic Illn

The Perceived Adjustment to Chronic Illness Scale (PACIS): a global indicator of coping for operable breast cancer patients in clinical trials

✍ Christoph Hürny; Jürg Bernhard; Marisa Bacchi; Brigitte Wegberg; Michele Tomamic 📂 Article 📅 1993 🏛 Springer-Verlag 🌐 English ⚖ 920 KB

Subjective well-being is a major aspect of quality of life and is therefore increasingly used as an endpoint in clinical trials. It is influenced to a great extent by the complex process of coping with the disease and its treatment. Assessment of coping is methodologically demanding, especially in l

A phase 1b trial of the combination of t

A phase 1b trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system malignancies

✍ Evan J. Wuthrick; Mitchell Kamrava; Walter J. Curran Jr; Maria Werner-Wasik; Kev 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 226 KB 👁 1 views